AdenocarcinomaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearGeneticPredispositionHormoneReceptorStatusSelf-examinationBRCAGeneKappaEpsilonMethotrexateFISHBrachytherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ACChemotherapyPagetDiseaseCalcificationsmTORInhibitorsMRIECOGScorePathologicResponseFibroadenomaKi-67RateHerceptinAdjuvantTherapyDoseDenseTherapyAngiogenesisPaclitaxelFlowCytometryChemotherapyCDK4/6InhibitorsBilateralProphylacticMastectomyTumorGradeBiopsyMorpheaLumpIn-situCarcinomaPalpationApoptosisAlopeciaMegestrolAcetateLCISPI3KinaseInhibitorsGermlineMutationRADRelapseCachexiaBevacizumabMultifocalTumorsWomen ages40+ shouldhave a clinicalbreast examat least yearlyDoxorubicinIntraductalPapillomaBI-RADSLymphNodeStatusCytostaticOvarianSuppressionStagingImmunotherapyGuaranteedRenewableInsuranceHER-2AnastrozoleLumpectomyChemopreventionHormoneReplacementTherapyAyurvedaDocetaxelFamilyHistoryEGFRMastectomyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55CMFChemotherapy5-FluorouracilTyrosine-KinaseInhibitorLymphoscintigraphy1 in 8womenDown-StagingTriple +/-BreastCancerEstrogen/EstradiolCo-survivorAntibodyTherapyDefinitiveSurgeryCapecitabinePalbociclibAromataseInhibitorsMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltRaloxifeneMultimodalityTherapyGeneticCounselingSERMOligometastasesCAMCheckpointInhibitorBreastCancerCyclophosphamideAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerMetastasisER+/-DimplingAntiemeticsCystNeoadjuvantTherapyTamoxifenPrecisionMedicineLapatinibProgestinAdvocacyGailModelAbsoluteRiskWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PARPInhibitorsRadiotherapyPhysicalactivity mayreduce therisk of breastcancersBOCAPhyllodesTumorBreastTomosynthesisMastodyniaGeneMutationAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCytotoxicAdenocarcinomaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearGeneticPredispositionHormoneReceptorStatusSelf-examinationBRCAGeneKappaEpsilonMethotrexateFISHBrachytherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ACChemotherapyPagetDiseaseCalcificationsmTORInhibitorsMRIECOGScorePathologicResponseFibroadenomaKi-67RateHerceptinAdjuvantTherapyDoseDenseTherapyAngiogenesisPaclitaxelFlowCytometryChemotherapyCDK4/6InhibitorsBilateralProphylacticMastectomyTumorGradeBiopsyMorpheaLumpIn-situCarcinomaPalpationApoptosisAlopeciaMegestrolAcetateLCISPI3KinaseInhibitorsGermlineMutationRADRelapseCachexiaBevacizumabMultifocalTumorsWomen ages40+ shouldhave a clinicalbreast examat least yearlyDoxorubicinIntraductalPapillomaBI-RADSLymphNodeStatusCytostaticOvarianSuppressionStagingImmunotherapyGuaranteedRenewableInsuranceHER-2AnastrozoleLumpectomyChemopreventionHormoneReplacementTherapyAyurvedaDocetaxelFamilyHistoryEGFRMastectomyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55CMFChemotherapy5-FluorouracilTyrosine-KinaseInhibitorLymphoscintigraphy1 in 8womenDown-StagingTriple +/-BreastCancerEstrogen/EstradiolCo-survivorAntibodyTherapyDefinitiveSurgeryCapecitabinePalbociclibAromataseInhibitorsMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltRaloxifeneMultimodalityTherapyGeneticCounselingSERMOligometastasesCAMCheckpointInhibitorBreastCancerCyclophosphamideAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerMetastasisER+/-DimplingAntiemeticsCystNeoadjuvantTherapyTamoxifenPrecisionMedicineLapatinibProgestinAdvocacyGailModelAbsoluteRiskWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PARPInhibitorsRadiotherapyPhysicalactivity mayreduce therisk of breastcancersBOCAPhyllodesTumorBreastTomosynthesisMastodyniaGeneMutationAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCytotoxic

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. Adenocarcinoma
  2. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  3. Genetic Predisposition
  4. Hormone Receptor Status
  5. Self-examination
  6. BRCA Gene
  7. Kappa Epsilon
  8. Methotrexate
  9. FISH
  10. Brachytherapy
  11. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  12. AC Chemotherapy
  13. Paget Disease
  14. Calcifications
  15. mTOR Inhibitors
  16. MRI
  17. ECOG Score
  18. Pathologic Response
  19. Fibroadenoma
  20. Ki-67 Rate
  21. Herceptin
  22. Adjuvant Therapy
  23. Dose Dense Therapy
  24. Angiogenesis
  25. Paclitaxel
  26. Flow Cytometry
  27. Chemotherapy
  28. CDK4/6 Inhibitors
  29. Bilateral Prophylactic Mastectomy
  30. Tumor Grade
  31. Biopsy
  32. Morphea
  33. Lump
  34. In-situ Carcinoma
  35. Palpation
  36. Apoptosis
  37. Alopecia
  38. Megestrol Acetate
  39. LCIS
  40. PI3 Kinase Inhibitors
  41. Germline Mutation
  42. RAD
  43. Relapse
  44. Cachexia
  45. Bevacizumab
  46. Multifocal Tumors
  47. Women ages 40+ should have a clinical breast exam at least yearly
  48. Doxorubicin
  49. Intraductal Papilloma
  50. BI-RADS
  51. Lymph Node Status
  52. Cytostatic
  53. Ovarian Suppression
  54. Staging
  55. Immunotherapy
  56. Guaranteed Renewable Insurance
  57. HER-2
  58. Anastrozole
  59. Lumpectomy
  60. Chemoprevention
  61. Hormone Replacement Therapy
  62. Ayurveda
  63. Docetaxel
  64. Family History
  65. EGFR
  66. Mastectomy
  67. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  68. CMF Chemotherapy
  69. 5-Fluorouracil
  70. Tyrosine-Kinase Inhibitor
  71. Lymphoscintigraphy
  72. 1 in 8 women
  73. Down-Staging
  74. Triple +/- Breast Cancer
  75. Estrogen/Estradiol
  76. Co-survivor
  77. Antibody Therapy
  78. Definitive Surgery
  79. Capecitabine
  80. Palbociclib
  81. Aromatase Inhibitors
  82. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  83. Raloxifene
  84. Multimodality Therapy
  85. Genetic Counseling
  86. SERM
  87. Oligometastases
  88. CAM
  89. Checkpoint Inhibitor
  90. Breast Cancer
  91. Cyclophosphamide
  92. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  93. Metastasis
  94. ER +/-
  95. Dimpling
  96. Antiemetics
  97. Cyst
  98. Neoadjuvant Therapy
  99. Tamoxifen
  100. Precision Medicine
  101. Lapatinib
  102. Progestin
  103. Advocacy
  104. Gail Model
  105. Absolute Risk
  106. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  107. PARP Inhibitors
  108. Radiotherapy
  109. Physical activity may reduce the risk of breast cancers
  110. BOCA
  111. Phyllodes Tumor
  112. Breast Tomosynthesis
  113. Mastodynia
  114. Gene Mutation
  115. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  116. Cytotoxic